“Tralokinumab Monotherapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Regional Differences in Baseline Disease Characteristics and Prior Treatment in the ECZTRA 1 and ECZTRA 2 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s101, https://doi.org/10.25251/skin.4.supp.101.